Table 3.
Risk of bias of studies included
| Study | Parallelism of groups | Comparability of groups | Blinding | Selective reporting improbable | Absence of other factors potentially causing bias | Risk of bias: study level | Risk of bias: outcome level | |
|---|---|---|---|---|---|---|---|---|
| Patients | Treating staff | |||||||
| Carlson 2021 [18, 19] | Yes | Yes | No | No | Unclear | Noa | High | High |
| Myrseth 2009 [20] | Yes | Nob | No | No | Unclear | Yes | High | High |
| Pollock 2006 [21] | Yes | Noc | No | No | Unclear | Yes | High | High |
apatients were screened for inclusion criteria between 2005 and 2019, although the study start date was reported as 2014. Thus, it remains unclear for what proportion of patients the survey was at least partially retrospective (“obtained by medical record review”). Based on all publications, it cannot be assumed that this is a retrospective study
balthough the essential data are available at baseline (age, sex, symptom severity, and tumour size), the groups differ in age by an average of 5.0 years (p = 0.06)
calthough the essential data are available at baseline (age, sex, symptom severity, and tumour size), the groups differ statistically significantly in age by an average of 5.7 years (p = 0.03)